SCHEMBL394487

SCHEMBL394487

NC(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL397274 0.96 LMNA (0.44) LMNATHRB
SCHEMBL394637 0.96 LMNA (0.44) LMNATHRB
SCHEMBL394884 0.96 LMNA (0.44) LMNATHRB
SCHEMBL4350577 0.96 LMNA (0.44) LMNATHRB
SCHEMBL345309 0.96 LMNA (0.44) LMNATHRB
SCHEMBL396607 0.96 LMNA (0.44) LMNATHRB
SCHEMBL637823 0.96 LMNA (0.44) LMNATHRB
SCHEMBL7128082 0.96 LMNA (0.44) LMNATHRB
SCHEMBL394687 0.96 LMNA (0.44) LMNATHRB
SCHEMBL344486 0.96 LMNA (0.44) LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 541 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250381232-A1 BONE DERIVED FIBERS AND OXYGENATED WOUND TREATMENTS TETROUS INC (US) 2025-12-18 US claimed
US-12419916-B2 Bone derived fibers and oxygenated wound treatments TETROUS, INC. (US) 2025-09-23 US claimed
EP-4520312-A2 THERAPEUTIC GAS INFUSED COSMETIC AND METHODS OF INFUSION Tetrous, Inc. (US) 2025-03-12 EP claimed
EP-3664770-B1 THERAPEUTIC GAS INFUSED COSMETIC AND METHODS OF INFUSION TETROUS INC (US) 2024-12-04 EP claimed
CN-118136967-B Lithium metal battery and preparation method and application thereof 蜂巢能源科技股份有限公司 2024-08-06 CN claimed
CN-118136967-A Lithium metal battery and preparation method and application thereof 蜂巢能源科技股份有限公司 2024-06-04 CN claimed
CN-111356432-B Cosmetic product for therapeutic gas infusion and method of infusion 特劳斯公司 2024-05-31 CN claimed
CN-117942772-A Anti-pollution film and preparation method thereof 中国石油化工股份有限公司 2024-04-30 CN claimed
EP-3540026-B1 WATER REPELLENT OIL REPELLENT ARTICLE, METHOD FOR PRODUCING SAME, AND WATER REPELLENT OIL REPELLENT AGENT COMPOSITION AGC INC (JP) 2024-04-24 EP claimed
US-20230355682-A1 BONE DERIVED FIBERS AND OXYGENATED WOUND TREATMENTS TETROUS, INC. 2023-11-09 US claimed
US-20120082704-A1 Oxygenated demineralized bone matrix for use in bone growth YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) 2012-04-05 US claimed
EP-1113026-B1 Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL CO (JP) 2009-12-09 EP claimed
US-7129200-B2 Domestic fabric article refreshment in integrated cleaning and treatment processes PROCTER & GAMBLE COMPANY (US) 2006-10-31 US claimed
US-20060234891-A1 Fabric article treatment appliance NOYES ANNA V 2006-10-19 US claimed
US-20050003977-A1 Composition for cleaning DAIKIN INDUSTRIES, LTD. (JP) 2005-01-06 US claimed
EP-1447440-A1 COMPOSITION FOR CLEANING Daikin Industries, Ltd. (JP) 2004-08-18 EP claimed
US-20020160272-A1 Process for producing a modified electrolyte and the modified electrolyte KABUSHIKI KAISHA TOYOTA CHUO (JP) 2002-10-31 US claimed
EP-0455528-B1 COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION CONTAINING VESICLES FORMED OF A MIXTURE OF PHOSPHOLIPIES/GLYCOLIPIDS L'OREAL (FR) 1993-07-14 EP claimed
EP-0455528-A1 Cosmetic or dermopharmaceutical composition containing vesicles formed of a mixture of phospholipies/glycolipids L'OREAL (FR) 1991-11-06 EP claimed
US-3989843-A Emulsification of fluorocarbon compounds for biological application as oxygen transporters PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1976-11-02 US claimed